Healthcare -
Biotechnology - NASDAQ - US
$ 57.76
8.14 %
$ 4.33 B
Market Cap
-16.6
P/E
SWTX - COST OF REVENUE
Cost of Revenue SWTX - SpringWorks Therapeutics, Inc.
12.6 M
LAST VALUE
157.28%
2 YEAR CAGR
130.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR